When should I stop taking Wegovy (semaglutide) before getting pregnant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Stop Wegovy Before Pregnancy

Stop Wegovy (semaglutide) at least 2 months before attempting to conceive. 1

FDA-Mandated Discontinuation Timeline

The FDA drug label for semaglutide explicitly states that women should discontinue the medication at least 2 months before a planned pregnancy due to semaglutide's long washout period. 1 This recommendation is based on the drug's pharmacokinetic profile rather than clinical judgment.

Pharmacokinetic Rationale

  • Semaglutide has a 7-day half-life, requiring 4-5 weeks to reach steady state and an equivalent time for elimination. 2
  • The 2-month (8-week) discontinuation window allows approximately 5 half-lives to pass, ensuring near-complete drug clearance before conception. 2
  • This extended washout period is necessary because semaglutide is a long-acting GLP-1 receptor agonist with sustained systemic exposure. 2

Comparison to Other Teratogenic Medications

The 2-month timeline for Wegovy is notably shorter than other medications requiring pre-conception discontinuation:

  • Methotrexate requires 3 months before attempting conception due to teratogenicity risk. 3
  • JAK inhibitors and sphingosine-1-P modulators require 3 months before conception. 3
  • Mycophenolate requires 6 weeks before conception. 4

This places semaglutide in an intermediate category—requiring more planning than some medications but less than highly teratogenic agents like methotrexate.

Essential Pre-Conception Measures

Use reliable contraception while taking Wegovy until the 2-month washout period is complete. 4 This prevents unintended pregnancy exposure during the elimination phase.

Transition to pregnancy-safe weight management strategies during the 2-month washout period, including:

  • Nutritional optimization and lifestyle modifications 3
  • Alternative pregnancy-compatible treatments for underlying conditions (diabetes, obesity) 5
  • Daily folic acid supplementation (400 μg/day for general population) 3
  • Daily vitamin D supplementation 3

Critical Timing Considerations

If pregnancy occurs while taking Wegovy, stop the medication immediately upon pregnancy discovery and seek obstetric counseling. 3 While the FDA label emphasizes planned discontinuation, unplanned pregnancy requires immediate cessation.

Plan for at least 3 months of disease control (if using Wegovy for diabetes) before conception when possible, though the mandatory 2-month drug washout is the minimum requirement. 3

Common Pitfalls to Avoid

  • Do not assume shorter discontinuation periods are adequate—the 2-month timeline is based on semaglutide's unique pharmacokinetics and cannot be shortened. 1, 2
  • Do not continue Wegovy during early pregnancy thinking first-trimester exposure is safe—the FDA specifically requires pre-conception discontinuation. 1
  • Do not delay contraception counseling—women of reproductive age on Wegovy need reliable birth control until the full washout period is complete. 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timing for Stopping Spironolactone Before Conception

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Pre-Conception Planning for Ozempic Discontinuation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.